Pramodini Medicare Limited (NSE:PRAMODINI)

India · Delayed Price · Currency is INR

127.20

-1.00 (-0.78%)

At close: Sep 10, 2026

Market Cap	2.61B
Revenue (ttm)	622.88M +148.4%
Net Income	173.77M +255.1%
EPS	10.41 +175.1%
Shares Out	22.05M
PE Ratio	11.38
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	298,800
Open	130.10
Previous Close	128.20
Day's Range	125.10 - 135.90
52-Week Range	111.55 - 137.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Pramodini Medicare

Pramodini Medicare Limited provides diagnostic service in India. The company offers radiology, which covers magnetic resonance imaging (MRI), computed tomography (CT scan), X-ray, ultrasound, mammography, Dexa scan, and intervention radiology; clinical laboratory, which includes hematology, microbiology, immunology, pathology, and biochemistry; and nuclear medicine, which includes PET-CT (Positron Emission Tomography-Computed Tomography), SPECT (Single Photon Emission Computed Tomography), and nuclear therapy services. It also provides healthca... [Read more]

Industry Medical Laboratories

Founded 1986

Employees 161

Stock Exchange National Stock Exchange of India

Ticker Symbol PRAMODINI

Full Company Profile

Financial Performance

In fiscal year 2026, Pramodini Medicare's revenue was 622.88 million, an increase of 62.90% compared to the previous year's 382.38 million. Earnings were 173.77 million, an increase of 57.58%.

Financial Statements